Brian Tyler

Stories

McKesson agrees to buy Precision Medicine Group in $2.25B deal

As of August 2026: Leading McKesson's oncology and specialty services strategy

The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.

Updated Aug 26